Photocure As

USPTO Granted Patents = 5

Forward Citations = 140

Loading Chart...

12 inventors (with patents filed for the assignee):

Johan E Moan (5 out of 14 patents)

Qian Peng (3 out of 11 patents)

Trond Warloe (3 out of 11 patents)

4. Kristian Berg (2 out of 13 patents)

5. Karl E Gierskcky (2 out of 9 patents)

6. Harald Steen (2 out of 10 patents)

7. Alf Bjorseth (2 out of 7 patents)

8. Jahn M Nesland (1 out of 2 patents)

9. Karl E Giercksky (1 out of 1 patent)

10. Anders Høgset (1 out of 4 patents)

11. Kirsten Sandvik (1 out of 1 patent)

12. Kirsten Sandvig (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 6750212 - Photochemotherapeutic compositions (2004-06-15),

2. 6680301 - Transfer of molecules into the cytosol of cells (2004-01-20),

3. 6492420 - Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy (2002-12-10),

4. 6034267 - Esters of 5-aminolevulinic acid as photosensitizing agents in (2000-03-07),

5. 5876989 - Transfer of molecules into the cytosol of cells (1999-03-02),

Photocure is a specialty pharmaceutical company focusing on urology and oncology. The company is a world leader in photodynamic diagnosis and treatment, offering innovative solutions for patients with bladder cancer. Photocure's flagship product, Cysview, is an imaging agent used to detect bladder cancer during cystoscopy procedures. With a strong focus on research and development, Photocure is committed to improving outcomes for patients with various urological and oncological conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#23 in

#311 in Norway

NO